995247940	995247940	CD	B-NP	O
|	|	NNP	I-NP	O
ABOHS	ABOHS	NNP	I-NP	O
|	|	VBD	B-VP	O
01328259	01328259	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
983241	983241	CD	B-NP	O
|	|	CC	I-NP	O
8/25/1998	8/25/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CEREBRO	CEREBRO	NNP	I-NP	I-protein
VASCULAR	VASCULAR	NNP	I-NP	I-protein
ACCIDENT	ACCIDENT	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/10/1998	4/10/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/19/1998	1/19/1998	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
LEFT	LEFT	NN	B-NP	O
SUBCORTICAL	SUBCORTICAL	NN	I-NP	O
STROKE	STROKE	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
MULTINODULAR	MULTINODULAR	NN	I-NP	O
GOITER	GOITER	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ANEMIA	ANEMIA	NNP	I-NP	O
,	,	,	O	O
SICKLE	SICKLE	NNP	B-NP	O
CELL	CELL	NNP	I-NP	O
TRAIT	TRAIT	NNP	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
POST	POST	NNP	I-NP	O
TOTAL	TOTAL	NNP	I-NP	O
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
HYSTERECTOMY	HYSTERECTOMY	NNP	I-NP	O
,	,	,	O	O
CERVICAL	CERVICAL	NNP	B-NP	O
DYSPLASIA	DYSPLASIA	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BURSITIS	BURSITIS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
MULTIPLE	MULTIPLE	NNP	I-NP	O
SITES	SITES	NNP	I-NP	O
OF	OF	IN	B-PP	O
ARTHRITIS	ARTHRITIS	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HISTORY	HISTORY	NN	I-NP	B-protein
OF	OF	IN	B-PP	I-protein
PHYSICAL	PHYSICAL	NNP	B-NP	O
ABUSE	ABUSE	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
VITILIGO	VITILIGO	NNP	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HEMORRHOIDS	HEMORRHOIDS	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Approximately	Approximately	RB	B-ADVP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
preparing	prepare	VBG	B-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
decrease	decrease	NN	B-NP	O
feeling	feeling	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
arm	arm	NN	I-NP	O
clumsiness	clumsiness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
there	there	RB	B-ADVP	O
all	all	DT	B-NP	O
day	day	NN	I-NP	O
long	long	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
fell	fall	VBD	B-VP	O
onto	onto	IN	B-PP	O
her	her	PRP$	B-NP	O
bottom	bottom	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
unsteadiness	unsteadiness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
couch	couch	NN	I-NP	O
,	,	,	O	O
except	except	IN	B-SBAR	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
water	water	NN	B-NP	O
since	since	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
stand	stand	VB	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
event	event	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
paralysis	paralysis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
similar	similar	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
before	before	IN	B-PP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
waited	wait	VBN	I-VP	O
for	for	IN	B-SBAR	O
it	it	PRP	B-NP	O
to	to	TO	B-VP	O
resolve	resolve	VB	I-VP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
had	have	VBD	B-VP	O
lasted	last	VBN	I-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
notice	notice	VB	I-VP	O
dysarthria	dysarthria	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
insulin	insulin	NN	B-NP	B-protein
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
decreased	decrease	VBN	I-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
swallowing	swallow	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	I-NP	O
vomiting	vomiting	NN	I-NP	O
or	or	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
head	head	NN	I-NP	O
or	or	CC	I-NP	O
neck	neck	NN	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
vertigo	vertigo	NN	I-NP	O
or	or	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
photophobia	photophobia	NN	I-NP	O
or	or	CC	I-NP	O
neck	neck	NN	I-NP	O
stiffness	stiffness	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
multinodular	multinodular	JJ	B-NP	O
goiter	goiter	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
and	and	CC	O	O
sickle	sickle	NN	B-NP	O
cell	cell	NN	I-NP	O
trait	trait	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
dysplasia	dysplasia	NN	I-NP	O
,	,	,	O	O
bursitis	bursitis	NN	B-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
,	,	,	O	O
just	just	RB	B-NP	O
a	a	DT	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
abuse	abuse	NN	I-NP	O
and	and	CC	I-NP	O
vitiligo	vitiligo	NN	I-NP	O
,	,	,	O	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
12.5	12.5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
once	once	IN	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
5	5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
once	once	IN	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Taxol	Taxol	NN	B-NP	O
28	28	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
once	once	IN	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Premarin	Premarin	NN	B-NP	O
0.625	0.625	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
once	once	IN	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Trazodone	Trazodone	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
14	14	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	O
and	and	CC	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
Ansaid	Ansaid	NNP	B-NP	O
100	100	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
joint	joint	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
reportedly	reportedly	RB	B-ADVP	O
taking	take	VBG	B-VP	O
a	a	DT	B-NP	O
baby	baby	NN	I-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
once	once	IN	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
disability	disability	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
widow	widow	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clear	clear	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	I-NP	O
ethanol	ethanol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ADLs	ADL	NNS	B-NP	B-protein
and	and	CC	O	O
mobility	mobility	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Familial	Familial	JJ	B-NP	O
intermittent	intermittent	JJ	I-NP	O
paralytic	paralytic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
97.1	97.1	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
110	110	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/70	130/70	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Glucose	Glucose	NN	B-NP	O
is	be	VBZ	B-VP	O
388	388	CD	B-NP	O
.	.	.	O	O

Mental	Mental	JJ	B-NP	O
status	status	NN	I-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
following	follow	VBG	B-VP	O
three	three	CD	B-NP	O
step	step	NN	I-NP	O
command	command	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
midline	midline	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
apraxia	apraxia	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
dysarthria	dysarthria	NN	I-NP	O
.	.	.	O	O

Repetition	Repetition	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Memory	Memory	NN	B-NP	B-protein
3/3	3/3	CD	I-NP	I-protein
immediately	immediately	RB	B-ADVP	O
and	and	CC	O	O
3/3	3/3	CD	B-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
3-2	3-2	CD	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
central	central	JJ	I-NP	O
facial	facial	JJ	I-NP	O
paralysis	paralysis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pallor	pallor	NN	I-NP	O
or	or	CC	I-NP	O
droop	droop	NN	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
sensation	sensation	NN	I-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
,	,	,	O	O
pinprick	pinprick	NN	B-NP	O
and	and	CC	I-NP	O
temperature	temperature	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Tears	Tear	NNS	B-NP	O
well	well	RB	B-ADVP	O
bilaterally	bilaterally	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
shrug	shrug	VB	I-VP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
and	and	CC	I-NP	O
tone	tone	NN	I-NP	O
flaccid	flaccid	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	B-protein
hemiplegia	hemiplegia	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
can	can	MD	B-VP	O
only	only	RB	I-VP	O
wiggle	wiggle	VB	I-VP	O
toes	toe	NNS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
strength	strength	NN	B-NP	B-protein
4-5/5	4-5/5	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
poor	poor	JJ	I-NP	B-protein
effort	effort	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Deep	Deep	JJ	B-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
biceps	bicep	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
,	,	,	O	O
0-1	0-1	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
ankle	ankle	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
upgoing	upgoe	VBG	I-NP	O
right	right	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
sensation	sensation	NN	I-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
,	,	,	O	O
pinprick	pinprick	NN	B-NP	O
and	and	CC	I-NP	O
vibration	vibration	NN	I-NP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
including	include	VBG	I-NP	O
trunk	trunk	NN	I-NP	O
.	.	.	O	O

Gait	Gait	VBD	B-VP	O
not	not	RB	I-VP	O
assessed	assess	VBN	I-VP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Atraumatic	Atraumatic	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
supple	supple	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Sinus	Sinus	NNP	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
104	104	CD	B-NP	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
on	on	IN	B-PP	O
8/17/98	8/17/98	CD	B-NP	O
showed	show	VBD	B-VP	O
low	low	JJ	B-NP	O
density	density	NN	I-NP	O
area	area	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
limb	limb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
intracapsular	intracapsular	JJ	I-NP	O
capsule	capsule	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
age	age	NN	I-NP	O
appropriate	appropriate	JJ	I-NP	O
involutional	involutional	JJ	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
353	353	CD	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.9	4.9	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
33	33	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	B-protein
10.3	10.3	CD	I-NP	I-protein
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.0	2.0	CD	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
0.09	0.09	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
8.4	8.4	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39.8	39.8	CD	I-NP	I-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
367	367	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
12.1	12.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
19.5	19.5	CD	I-NP	I-protein
.	.	.	O	O

INR	INR	NN	B-NP	O
1.0	1.0	CD	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NNP	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Lofstrom	Lofstrom	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-year-old	57-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
multinodular	multinodular	JJ	B-NP	O
goiter	goiter	NN	I-NP	O
,	,	,	O	O
arthritis	arthritis	NN	B-NP	O
and	and	CC	O	O
questionable	questionable	JJ	B-NP	O
recurrent	recurrent	JJ	I-NP	O
bouts	bout	NNS	I-NP	O
of	of	IN	B-PP	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
sided	sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
numbness	numbness	NN	I-NP	O
and	and	CC	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
arm	arm	NN	I-NP	O
clumsiness	clumsiness	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
dysarthria	dysarthria	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

NEUROLOGY	NEUROLOGY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
probable	probable	JJ	I-NP	O
subcortical	subcortical	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
with	with	IN	B-PP	O
preservation	preservation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
speech	speech	NN	I-NP	O
processing	processing	NN	I-NP	O
abilities	ability	NNS	I-NP	O
with	with	IN	B-PP	O
dense	dense	JJ	B-NP	O
motor	motor	NN	I-NP	O
and	and	CC	O	O
sensory	sensory	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	B-VP	O
potentially	potentially	RB	I-VP	O
represent	represent	VB	I-VP	O
an	an	DT	B-NP	O
MCA	MCA	NNP	I-NP	O
branch	branch	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
edema	edema	NN	I-NP	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
lacuna	lacuna	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
embolic	embolic	JJ	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CKs	CK	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
25	25	CD	B-NP	O
,	,	,	I-NP	O
37	37	CD	I-NP	O
,	,	,	I-NP	O
37	37	CD	I-NP	O
and	and	CC	I-NP	O
32	32	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
monitor	monitor	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmia	arrhythmia	NN	B-NP	O
.	.	.	O	O

she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
subcu	subcu	NN	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
full	full	JJ	B-NP	O
dose	dose	NN	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
work	work	VB	I-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
stroke	stroke	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
done	done	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
calculated	calculate	VBD	B-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-ADJP	O
than	than	IN	B-PP	O
nonspecific	nonspecific	JJ	B-NP	O
septal	septal	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
regional	regional	JJ	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
early	early	JJ	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
annular	annular	JJ	I-NP	O
calcification	calcification	NN	I-NP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
some	some	DT	B-NP	O
increased	increase	VBN	I-NP	O
excursion	excursion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
leaflet	leaflet	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
trivial	trivial	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Trileaflet	Trileaflet	NN	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
without	without	IN	B-PP	O
dysfunction	dysfunction	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
plus	plus	CC	O	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Peak	Peak	JJ	B-NP	O
doppler	doppler	NN	I-NP	O
flow	flow	NN	I-NP	O
velocity	velocity	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
reached	reach	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
meters	meter	NNS	I-NP	O
per	per	IN	B-PP	O
second	second	JJ	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
effusion	effusion	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
carotid	carotid	JJ	B-NP	O
noninvasive	noninvasive	JJ	I-NP	O
studies	study	NNS	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hemodynamically	hemodynamically	RB	B-NP	O
significant	significant	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
either	either	CC	B-NP	O
carotid	carotid	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
arteries	artery	NNS	I-NP	O
having	have	VBG	B-VP	O
minimal	minimal	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
1-25	1-25	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MRI/MRA	MRI/MRA	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
potential	potential	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
MRI	MRI	NNP	B-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
focal	focal	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
T2	T2	NN	I-NP	O
signal	signal	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
limb	limb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
capsule	capsule	NN	I-NP	O
,	,	,	O	O
close	close	VB	B-VP	O
the	the	DT	B-NP	O
genu	genu	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
area	area	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
restricted	restricted	JJ	B-NP	O
diffusion	diffusion	NN	I-NP	O
on	on	IN	B-PP	O
EPI	EPI	NN	B-NP	B-DNA
diffusion	diffusion	NN	I-NP	I-DNA
,	,	,	O	I-DNA
weighted	weight	VBD	B-VP	I-DNA
sequence	sequence	NN	B-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
similar	similar	JJ	I-NP	O
smaller	small	JJR	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
signal	signal	NN	B-NP	O
abnormality	abnormality	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
globus	globus	NN	I-NP	O
pallidus	pallidus	NN	I-NP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
capsule	capsule	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
areas	area	NNS	I-NP	O
represent	represent	VBP	B-VP	O
subacute	subacute	JJ	B-NP	O
infarctions	infarction	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ventricles	ventricle	NNS	I-NP	O
and	and	CC	I-NP	O
sulci	sulcus	NNS	I-NP	O
were	be	VBD	B-VP	O
minimally	minimally	RB	B-ADJP	O
prominent	prominent	JJ	I-ADJP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
age	age	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
signal	signal	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Major	Major	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
flow	flow	NN	I-NP	O
voids	void	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
mass	mass	NN	I-NP	O
or	or	CC	I-NP	O
mass	mass	NN	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
D	D	NNP	I-NP	O
,	,	,	O	O
TOF	TOF	NN	B-NP	O
MRN	MRN	NN	I-NP	O
angiogram	angiogram	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
circle	circle	NN	I-NP	O
of	of	IN	B-PP	O
Willis	Willis	NNP	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
major	major	JJ	I-NP	O
tributaries	tributary	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

Incidental	Incidental	JJ	B-NP	O
note	note	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
right	right	JJ	I-NP	O
vertebral	vertebral	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
formal	formal	JJ	I-NP	O
impression	impression	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
subacute	subacute	JJ	B-NP	O
infarcts	infarct	NNS	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
limb	limb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
capsule	capsule	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
globus	globus	NN	I-NP	O
pallidus	pallidus	NN	I-NP	O
.	.	.	O	O

Unremarkable	Unremarkable	JJ	B-NP	O
MR	MR	NN	I-NP	O
angiogram	angiogram	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
circle	circle	NN	I-NP	O
of	of	IN	B-PP	O
Willis	Willis	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
polymyalgias	polymyalgia	NNS	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
ESR	ESR	NN	I-NP	B-protein
and	and	CC	I-NP	O
C-reactive	C-reactive	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
ESR	ESR	NNP	I-NP	O
was	be	VBD	B-VP	O
46	46	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
C-reactive	C-reactive	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
1.13	1.13	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
stroke	stroke	NN	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	I-VP	O
comment	comment	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
vasculitic	vasculitic	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stroke	stroke	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
small	small	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
felt	feel	VBD	B-VP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
vasculitis	vasculitis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
suggested	suggest	VBD	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
to	to	TO	B-VP	O
alleviate	alleviate	VB	I-VP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
any	any	DT	B-NP	O
vasculitic	vasculitic	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
therefore	therefore	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
continuing	continue	VBG	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
checking	check	VBG	B-VP	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
homocystine	homocystine	NN	I-NP	O
which	which	WDT	B-NP	O
remains	remain	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
reviewing	review	VBG	B-VP	O
her	her	PRP$	B-NP	O
carotid	carotid	NN	I-NP	B-protein
studies	study	NNS	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
mentioned	mention	VBN	B-VP	O
above	above	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
continue	continue	VBP	B-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
occupational	occupational	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
speech	speech	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
and	and	CC	I-NP	O
OT	OT	NN	I-NP	O
were	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Speech	Speech	NN	B-NP	O
Therapy	Therapy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
continuing	continue	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
continuing	continue	VBG	B-NP	O
subcu	subcu	NN	I-NP	O
heparin	heparin	NN	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
immobile	immobile	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
between	between	IN	B-PP	O
140-160	140-160	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
between	between	IN	B-PP	O
85-90	85-90	CD	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
lying	lie	VBG	I-NP	O
position	position	NN	I-NP	O
as	as	RB	B-ADVP	O
much	much	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
activity	activity	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
participating	participate	VBG	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
PT/OT	PT/OT	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Norvasc	Norvasc	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
between	between	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
of	of	IN	B-PP	O
140-160	140-160	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
reinitiated	reinitiate	VBN	I-VP	O
until	until	IN	B-PP	O
roughly	roughly	RB	B-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
poor	poor	JJ	I-NP	O
return	return	NN	I-NP	O
of	of	IN	B-PP	O
function	function	NN	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
issues	issue	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
ready	ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
improve	improve	VB	I-VP	O
her	her	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
reinitiated	reinitiate	VBN	I-VP	O
gradually	gradually	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
between	between	IN	B-PP	O
140-160	140-160	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
85-90	85-90	CD	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
initiated	initiate	VBN	I-VP	O
roughly	roughly	RB	B-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
8/17/98	8/17/98	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
work	work	NN	I-NP	O
up	up	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
embolic	embolic	JJ	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
carotid	carotid	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

RHEUMATOLOGIC	RHEUMATOLOGIC	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
arthritic	arthritic	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
sed	se	VBN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
C-reactive	C-reactive	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
checked	check	VBD	B-VP	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
recommend	recommend	VB	I-VP	O
checking	check	VBG	I-VP	O
a	a	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
for	for	IN	B-PP	O
red	red	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
casts	cast	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
0-2	0-2	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
casts	cast	NNS	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
other	other	JJ	I-NP	O
recommendation	recommendation	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
to	to	TO	B-VP	O
alleviate	alleviate	VB	I-VP	O
left	left	JJ	B-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
recommended	recommend	VBD	B-VP	O
avoiding	avoid	VBG	I-VP	O
nonsteroidals	nonsteroidal	NNS	B-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
schedule	schedule	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
has	have	VBZ	B-VP	O
ranged	range	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
150	150	CD	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
200s	200s	CD	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diet	diet	NN	I-NP	O
returns	return	NNS	I-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
adjustments	adjustment	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
and	and	CC	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Premarin	Premarin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
decided	decide	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
neurologist	neurologist	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

FLUIDS	FLUIDS	NN	B-NP	O
,	,	,	I-NP	O
ELECTROLYTES	ELECTROLYTES	NN	I-NP	O
AND	AND	CC	I-NP	O
NUTRITION	NUTRITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
appeared	appear	VBD	B-VP	O
somewhat	somewhat	RB	I-VP	O
dehydrated	dehydrate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
rehydrated	rehydrate	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
good	good	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
eating	eat	VBG	I-VP	O
well	well	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Close	Close	JJ	B-NP	O
observation	observation	NN	I-NP	O
was	be	VBD	B-VP	O
paid	pay	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
including	include	VBG	B-PP	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
periodically	periodically	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
watched	watch	VBN	I-VP	O
carefully	carefully	RB	B-ADVP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
made	make	VBD	B-VP	O
a	a	DT	B-NP	O
comment	comment	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Team	Team	NNP	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
abused	abuse	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
social	social	JJ	I-NP	O
worker	worker	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
asked	ask	VBN	B-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
her	her	PRP	B-NP	O
regarding	regard	VBG	B-VP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
of	of	IN	B-PP	O
spouse	spouse	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
true	true	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
had	have	VBD	B-VP	O
hit	hit	VBN	I-VP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
forehead	forehead	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseball	baseball	NN	I-NP	O
bat	bat	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
died	die	VBD	B-VP	O
several	several	JJ	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
abuse	abuse	NN	I-NP	O
history	history	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
elicited	elicit	VBN	I-VP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
death	death	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
currently	currently	RB	B-ADVP	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
supportive	supportive	JJ	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
ready	ready	JJ	I-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
transfer	transfer	NN	I-NP	O
is	be	VBZ	B-VP	O
made	make	VBN	I-VP	O
available	available	JJ	B-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
along	along	RB	B-ADVP	O
with	with	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
RODGER	RODGER	NN	B-NP	O
FALIS	FALIS	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MW19	MW19	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JUAN	JUAN	NNP	B-NP	O
AMISANO	AMISANO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AI9	AI9	NN	I-NP	O
EB354/2097	EB354/2097	NN	I-NP	O
Batch	Batch	NN	I-NP	O
:	:	:	O	O
4280	4280	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

YTCBO390I	YTCBO390I	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/5/98	10/5/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/19/98	1/19/98	CD	B-NP	O

